Samir Dervisevic
Overview
Explore the profile of Samir Dervisevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coupland L, Woodward K, Dervisevic S, Hale R, Brolly S
Viruses
. 2024 May;
16(5).
PMID: 38793553
DNA assays for viral load (VL) monitoring are key tools in the management of immunocompromised patients with cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection. In this study, the analytical and...
2.
Singh B, Lant S, Cividini S, Cattrall J, Goodwin L, Benjamin L, et al.
PLoS One
. 2022 Jun;
17(6):e0263595.
PMID: 35653330
Background: Neurological COVID-19 disease has been reported widely, but published studies often lack information on neurological outcomes and prognostic risk factors. We aimed to describe the spectrum of neurological disease...
3.
Piec I, Cook L, Dervisevic S, Fraser W, Ruetten S, Berman M, et al.
Curr Res Transl Med
. 2022 Apr;
70(3):103344.
PMID: 35390564
Background: Most approved vaccines utilise a two-dose strategy. To enable larger groups of patients to receive the first dose, the UK government increased the gap between the two doses from...
4.
Hale R, Crowley P, Dervisevic S, Coupland L, Cliff P, Ebie S, et al.
Viruses
. 2021 Oct;
13(10).
PMID: 34696458
The emergence of variants of SARS-CoV-2 has created challenges for the testing infrastructure. Although large-scale genome sequencing of SARS-CoV-2 has facilitated hospital and public health responses, access to sequencing facilities...
5.
English E, Cook L, Piec I, Dervisevic S, Fraser W, John W
J Clin Microbiol
. 2021 Jul;
59(9):e0028821.
PMID: 34260272
In the initial stages of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, a plethora of new serology tests were developed and introduced to the global market. Many...
6.
Page A, Mather A, Le-Viet T, Meader E, Alikhan N, Kay G, et al.
Microb Genom
. 2021 Jun;
7(6).
PMID: 34184982
The COVID-19 pandemic has spread rapidly throughout the world. In the UK, the initial peak was in April 2020; in the county of Norfolk (UK) and surrounding areas, which has...
7.
Piec I, English E, Thomas M, Dervisevic S, Fraser W, John W
PLoS One
. 2021 Feb;
16(2):e0245914.
PMID: 33596236
In the emergency of the SARS-CoV-2 pandemic, great efforts were made to quickly provide serology testing to the medical community however, these methods have been introduced into clinical practice without...
8.
Baker D, Aydin A, Le-Viet T, Kay G, Rudder S, de Oliveira Martins L, et al.
Genome Med
. 2021 Feb;
13(1):21.
PMID: 33563320
We present CoronaHiT, a platform and throughput flexible method for sequencing SARS-CoV-2 genomes (≤ 96 on MinION or > 96 on Illumina NextSeq) depending on changing requirements experienced during the...
9.
Brown L, Ruis C, Clark I, Roy S, Brown J, Albuquerque A, et al.
J Allergy Clin Immunol
. 2019 Aug;
144(5):1450-1453.
PMID: 31415785
No abstract available.
10.
Edmunds K, Elrahman S, Bell D, Brainard J, Dervisevic S, Fedha T, et al.
Bull World Health Organ
. 2016 Jun;
94(6):424-32.
PMID: 27274594
Objective: To assess, within communities experiencing Ebola virus outbreaks, the risks associated with the disposal of human waste and to generate recommendations for mitigating such risks. Methods: A team with...